{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Illustrate comparisons to Sicklick 2019\n",
    "We investigated how highlights made by the Molecular Oncology Almanac compare to those made in the trial I-PREDICT. We create the following figures:\n",
    "\n",
    "1. Counts of therapies administered per patient (custom figure)\n",
    "2. Therapies by evidence for those (stacked bar charts)\n",
    "    * administered to patients in I-PREDICT\n",
    "    * highlighted by the Molecular Oncology Almanac\n",
    "3. Counts of (scatter plots)\n",
    "    * therapies\n",
    "    * thearpeutic strategy\n",
    "    * molecular features targeted\n",
    "    \n",
    "Lastly, we'll generate some summary statistics and findings which are of particularly of note."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Import"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import glob\n",
    "import math\n",
    "import matplotlib.pyplot as plt\n",
    "import matplotlib.gridspec as gridspec\n",
    "from matplotlib.patches import Patch\n",
    "from matplotlib.lines import Line2D\n",
    "import numpy\n",
    "import pandas\n",
    "\n",
    "import sys\n",
    "sys.path.append('../../common/')\n",
    "import settings\n",
    "settings.set_arial_as_font()\n",
    "\n",
    "from matplotlib import colors\n",
    "%matplotlib inline\n",
    "\n",
    "features = pandas.read_csv('merged-features.annotated.txt', sep='\\t')\n",
    "therapies = pandas.read_csv('therapies.annotated.txt', sep='\\t')\n",
    "\n",
    "def normalize_rgb(dictionary):\n",
    "    for color in dictionary.keys():\n",
    "        r, g, b = dictionary[color]\n",
    "        dictionary[color] = (r / 255., g / 255., b / 255.)\n",
    "    return dictionary\n",
    "def return_cmap_norm(normalized_rgb, bounds):\n",
    "    cmap = colors.ListedColormap(normalized_rgb)\n",
    "    norm = colors.BoundaryNorm(bounds, cmap.N)\n",
    "    return cmap, norm\n",
    "\n",
    "tableau = normalize_rgb({\n",
    "    'red': (198, 4, 4), 'blue': (48, 100, 147), 'purple': (167, 136, 168),\n",
    "    #'red': (221, 76, 78), 'purple': (166, 111, 151), 'blue': (68, 109, 157)\n",
    "})\n",
    "\n",
    "purple = '#A788A8'\n",
    "blue = '#306493'\n",
    "red = '#CC0000'\n",
    "green = '#49ae3e'\n",
    "orange = '#ec7b22'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['feature', 'feature_type', 'alteration_type', 'alteration',\n",
       "       'patient_id', 'ipredict_targeted', 'score_bin',\n",
       "       'sensitive_predictive_implication', 'resistance_predictive_implication',\n",
       "       'prognostic_predictive_implication', 'sensitive_score_bin',\n",
       "       'sensitive_therapy_name', 'sensitive_therapy_strategy',\n",
       "       'sensitive_therapy_type', 'sensitive_description', 'sensitive_citation',\n",
       "       'sensitive_url', 'resistance_score_bin', 'resistance_therapy_name',\n",
       "       'resistance_therapy_strategy', 'resistance_therapy_type',\n",
       "       'resistance_description', 'resistance_citation', 'resistance_url',\n",
       "       'prognostic_score_bin', 'favorable_prognosis', 'prognostic_description',\n",
       "       'prognostic_citation', 'prognostic_url'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "features.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['patient_id', 'therapy', 'study-evidence-strongest',\n",
       "       'almanac-evidence-strongest', 'included-in-overlapping-strategy',\n",
       "       'strategy', 'study-gave-as-matched-therapy',\n",
       "       'study-citations-used-for-patient', 'comment-on-study-citation',\n",
       "       'substrategy', 'almanac_top_recommendation_group'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def display_label(data, ax, min_x, min_y, index_value, fontsize=16, add_x=0, add_y=0):\n",
    "    x = data.loc[index_value, 'label_x']\n",
    "    y = data.loc[index_value, 'label_y']\n",
    "    \n",
    "    if (((x > 5) & (y > 5)) | (x > min_x) | (y > min_y)):\n",
    "        ax.annotate(index_value, (x + add_x, y + add_y), fontsize=fontsize)\n",
    "\n",
    "def label_by_height(data, ax, fontsize=16):\n",
    "    labels = []\n",
    "    count = 0\n",
    "    \n",
    "    for index in data.index:\n",
    "        labels.append('')\n",
    "    for index in data.index:\n",
    "        labels.append(data.loc[index, 'percent agree'])\n",
    "        \n",
    "    for i in ax.patches:\n",
    "        if count >= 6:\n",
    "            ax.text(i.get_x() + 0.1, i.get_y() + i.get_height() + 2, labels[count], \n",
    "                    fontsize=fontsize, color=purple, fontweight='semibold')\n",
    "        count += 1\n",
    "        \n",
    "def remove_spines(ax):\n",
    "    ax.spines['top'].set_visible(False)\n",
    "    ax.spines['bottom'].set_visible(False)\n",
    "    ax.spines['right'].set_visible(False)\n",
    "    ax.spines['left'].set_visible(False)\n",
    "\n",
    "def remove_ticks(ax,\n",
    "                 bottom=False, top=False, left=False, right=False,\n",
    "                 labelbottom=False, labeltop=True, labelleft=False, labelright=False):\n",
    "    ax.tick_params(\n",
    "        axis=\"both\", which=\"both\", \n",
    "        bottom=bottom, top=top, left=left, right=right,\n",
    "        labelbottom=labelbottom, labeltop=labeltop, labelleft=labelleft, labelright=labelright) \n",
    "    \n",
    "def roundup(x, n):\n",
    "    return int(int(math.ceil(x / n)) * n)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Counts of therapies administered per patient (custom figure)\n",
    "We will process the therapies dataframe to create a dataframe that shows: \n",
    "1. the number of therapies administered per patient by I-PREDICT on the left (blue)\n",
    "2. the number of therapies highlighted per patient by Molecular Oncology Almanac on the right (red)\n",
    "3. the number of these therapies that were involved in overlapping strategy for both sides (purple)\n",
    "\n",
    "This will be labeled as `data_s`. This was originally Figure 4A but was moved to the supplement."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "series_list = []\n",
    "for label, group in therapies.groupby('patient_id'):\n",
    "    total_therapies = group.shape[0]\n",
    "    idx_study = group['study-gave-as-matched-therapy'].notnull()\n",
    "    idx_almanac = group['almanac-evidence-strongest'].notnull()\n",
    "    idx_overlap = group['included-in-overlapping-strategy'].fillna(0).astype(int).eq(1)\n",
    "    \n",
    "    sum_overlap = group['included-in-overlapping-strategy'].fillna(0.0).astype(float).sum()\n",
    "    \n",
    "    study_overlap = group[idx_study & idx_overlap].shape[0]\n",
    "    almanac_overlap = group[idx_almanac & idx_overlap].shape[0]\n",
    "    \n",
    "    dictionary = {\n",
    "        'total': total_therapies,\n",
    "        'study': group[idx_study].shape[0],\n",
    "        'almanac': group[idx_almanac].shape[0],\n",
    "        'study_overlap': study_overlap,\n",
    "        'almanac_overlap': almanac_overlap,\n",
    "        'overlap': sum_overlap\n",
    "    }\n",
    "    series = pandas.Series(dictionary, name=label)\n",
    "    series_list.append(series)\n",
    "\n",
    "data = pandas.concat(series_list, axis=1).T.reset_index().rename(columns={'index': 'patient_id'})\n",
    "data['study_not_overlap'] = data['study'].subtract(data['study_overlap'])\n",
    "data['almanac_not_overlap'] = data['almanac'].subtract(data['almanac_overlap'])\n",
    "\n",
    "sort_columns = ['overlap', 'study', 'almanac']\n",
    "data = data.sort_values(sort_columns, ascending=True)\n",
    "\n",
    "data_s = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 540x720 with 4 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "font_size_legend = 15\n",
    "font_size_data = 16\n",
    "font_size_axis_label = 18\n",
    "font_size_tick_params = 18\n",
    "font_size_title_minor = 20\n",
    "font_size_title_major = 22\n",
    "\n",
    "figure = plt.figure(figsize=(7.5, 10))\n",
    "gs = figure.add_gridspec(nrows=3, ncols=2)\n",
    "gsA = gs[:,:].subgridspec(3, 2, height_ratios = [1, 20, 1], wspace=.00, hspace=0.0)\n",
    "\n",
    "# axA = Figure 3A. Comparison of therapy counts per patient, unique strategy and overlapping strategies\n",
    "# axA_top = legend, all columns and top two rows\n",
    "# axA_left = I-PREDICT, first three columns and then middle 14 rows\n",
    "# axA_right = MOAlmanac, second three columns and then middle 14 rows\n",
    "# axA_bottom = title, all columns and bottom two rows\n",
    "\n",
    "axA_top = figure.add_subplot(gsA[0, :])      # legend, all columns and top two rows\n",
    "axA_left = figure.add_subplot(gsA[1, 0])     # I-PREDICT, first three columns and then middle 14 rows\n",
    "axA_right = figure.add_subplot(gsA[1, 1])    # MOAlmanac, second three columns and then middle 14 rows\n",
    "axA_bottom = figure.add_subplot(gsA[2, :])   # title, all columns and bottom two rows\n",
    "\n",
    "#axA_left.annotate('', (0, 0.45), (0.36, 0.45), ha='right', va='center', size=25,\n",
    "#                   arrowprops=dict(arrowstyle='->', fc='k', ec='k', linewidth=2))\n",
    "#axA_top.annotate('Patients', (5, -5), (5, -5), ha='right', va='center', size=25,\n",
    "#                   arrowprops=dict(arrowstyle='->', fc='k', ec='k', linewidth=2))\n",
    "\n",
    "p_left = (data_s\n",
    "          .loc[:, ['study_overlap', 'study_not_overlap']]\n",
    "          .plot(kind='barh', stacked=True, ax=axA_left, width=1, \n",
    "                fontsize = font_size_data, \n",
    "                color=(purple, blue), edgecolor='white', zorder=3))\n",
    "\n",
    "p_right = (data_s\n",
    "          .loc[:, ['almanac_overlap', 'almanac_not_overlap']]\n",
    "          .plot(kind='barh', stacked=True, ax=axA_right, width=1, \n",
    "                fontsize = font_size_data, \n",
    "                color=(purple, red), edgecolor='white', zorder=3))\n",
    "\n",
    "for ax in [axA_bottom, axA_top]:\n",
    "    remove_ticks(ax, labeltop=False)\n",
    "\n",
    "for ax in [axA_left, axA_right]:\n",
    "    remove_ticks(ax, labeltop=True)\n",
    "    ax.grid(linestyle='--', linewidth=0.5, alpha=0.3, color='black', zorder=0)\n",
    "    ax.get_yaxis().set_visible(False)\n",
    "    ax.set_xticks([2, 4, 6, 8])\n",
    "    ax.set_xticklabels([2, 4, 6, 8])\n",
    "    ax.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "    \n",
    "axA_left.set_xlim(9, 0)\n",
    "axA_right.set_xlim(0, 9)\n",
    "\n",
    "axA_left.set_xlabel('# of therapies given\\nin I-PREDICT', \n",
    "                    fontsize = font_size_axis_label)\n",
    "axA_right.set_xlabel('# of therapies nominated by\\nMOAlmanac', \n",
    "                     fontsize = font_size_axis_label)\n",
    "axA_left.xaxis.set_label_position('top')\n",
    "axA_right.xaxis.set_label_position('top')\n",
    "\n",
    "#axA_left.text(-1, 60, 'Patients', rotation=90, fontsize = font_size_title_minor)\n",
    "\n",
    "for ax in [axA_left, axA_right, axA_top, axA_bottom]:\n",
    "    remove_spines(ax)\n",
    "\n",
    "title = 'Counts of therapies administered per patient (n=83) in\\n I-PREDICT & nominated by Molecular Oncology Almanac'\n",
    "axA_bottom.text(0.5, 0, title, fontsize=font_size_title_minor, \n",
    "                horizontalalignment='center', verticalalignment='center')\n",
    "\n",
    "legend_elements = [Patch(facecolor=blue, label='I-PREDICT\\n(unique strategy)'), \n",
    "                   Patch(facecolor=purple, label='Involved in an\\noverlapping strategy'),\n",
    "                   Patch(facecolor=red, label='MOAlmanac\\n(unique strategy)')]\n",
    "\n",
    "axA_left.legend(handles=legend_elements, \n",
    "               frameon=True, bbox_to_anchor=(0.8, 0.45),\n",
    "               fontsize = font_size_legend,  \n",
    "               ncol=1, facecolor='white', edgecolor='white')\n",
    "axA_right.get_legend().remove()\n",
    "\n",
    "folder_name = '../../figures/supplementary-figure-11'\n",
    "file_name = 'supplementary-figure-11'\n",
    "!mkdir -p $folder_name\n",
    "for suffix in ['svg', 'png', 'pdf']:\n",
    "    outname = f'{folder_name}/{file_name}.{suffix}'\n",
    "    plt.savefig(outname, format=suffix)\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_s.to_excel(f'{folder_name}/{file_name}.xlsx', index=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Therapies by evidence for those (stacked bar charts)\n",
    "We plot the evidence level for overlapping and and unique strategy when comparing I-PREDICT (`data_a0`) and the Molecular Oncology Almanac (`data_a1`)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "idx_overlap = therapies['included-in-overlapping-strategy'].fillna(0.0).eq(1.0)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Strategy of overlapping and unique therapies for I-PREDICT"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "column = 'study-evidence-strongest'\n",
    "overlap = 'Involved in common therapeutic strategy with\\nMolecular Oncology Almanac'\n",
    "unique = 'I-PREDICT\\n(unique therapeutic strategy)'\n",
    "percent = 'percent agree'\n",
    "\n",
    "therapies[column] = (therapies[column]\n",
    "                     .str.replace('No citation', 'Not based on molecular features'))\n",
    "\n",
    "data = pandas.DataFrame(columns = {overlap, unique}, index=therapies[column].dropna().unique())\n",
    "data[unique] = therapies[~idx_overlap][column].value_counts()\n",
    "data[overlap] = therapies[idx_overlap][column].value_counts()\n",
    "data[percent] = (data[overlap]\n",
    "                 .divide(data[unique].add(data[overlap]))\n",
    "                 .round(2)\n",
    "                 .multiply(100)\n",
    "                 .fillna(0)\n",
    "                 .astype(int)\n",
    "                 .astype(str) + '%')\n",
    "\n",
    "for index in data.index:\n",
    "    if len(data.loc[index, 'percent agree']) == 2:\n",
    "        data.loc[index, 'percent agree'] = ' ' + data.loc[index, 'percent agree']\n",
    "        \n",
    "order = ['Clinical trial', 'Clinical evidence', 'Preclinical', 'Inferential', \n",
    "         'Citation listed not applicable', 'Not based on molecular features']\n",
    "data = data.reindex(order)\n",
    "data = data.loc[:, [overlap, unique, percent]]\n",
    "\n",
    "data_a0 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Clinical trial                     94\n",
       "Preclinical                        20\n",
       "Not based on molecular features    19\n",
       "Citation listed not applicable      7\n",
       "Clinical evidence                   3\n",
       "Inferential                         2\n",
       "Name: study-evidence-strongest, dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies['study-evidence-strongest'].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Strategy of overlapping and unique therapies for Molecular Oncology Almanac"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "column = 'almanac-evidence-strongest'\n",
    "overlap = 'Involved in common therapeutic strategy\\nwith I-PREDICT'\n",
    "unique = 'Molecular Oncology Almanac\\n(unique therapeutic strategy)'\n",
    "percent = 'percent agree'\n",
    "\n",
    "data = pandas.DataFrame(columns = {overlap, unique}, index=therapies[column].dropna().unique())\n",
    "data[unique] = therapies[~idx_overlap][column].value_counts()\n",
    "data[overlap] = therapies[idx_overlap][column].value_counts()\n",
    "data[percent] = (data[overlap]\n",
    "                 .divide(data[unique].add(data[overlap]))\n",
    "                 .round(2)\n",
    "                 .multiply(100)\n",
    "                 .fillna(0)\n",
    "                 .astype(int)\n",
    "                 .astype(str) + '%')\n",
    "\n",
    "for index in data.index:\n",
    "    if len(data.loc[index, 'percent agree']) == 2:\n",
    "        data.loc[index, 'percent agree'] = ' ' + data.loc[index, 'percent agree']\n",
    "order = ['FDA-Approved', 'Guideline',  'Clinical trial', 'Clinical evidence', 'Preclinical', 'Inferential']\n",
    "data = data.reindex(order)\n",
    "\n",
    "data = data.loc[:, [overlap, unique, percent]]\n",
    "data_a1 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Preclinical          66\n",
       "FDA-Approved         40\n",
       "Clinical trial       25\n",
       "Clinical evidence    18\n",
       "Inferential          12\n",
       "Guideline            10\n",
       "Name: almanac-evidence-strongest, dtype: int64"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[column].value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Counts\n",
    "We create scatter plots comparing the molecular features targeted, therapeutic strategies, and specific therapies targeted and highlighted by the study and our methodology. Values from I-PREDICT will appear on the x-axis with Molecular Oncology Almanac on the y. Data tables will need to have additional columns for label display, which can be manually tweaked as needed for visualization."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Therapeutic strategies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "therapies['strategy'] = therapies['strategy'].str.replace(' inhibition', '')\n",
    "ipredict = therapies[~therapies['study-evidence-strongest'].isnull()]['strategy'].value_counts()\n",
    "almanac = therapies[~therapies['almanac-evidence-strongest'].isnull()]['strategy'].value_counts()\n",
    "strategy_list = therapies['strategy'].unique().tolist()\n",
    "\n",
    "data = pandas.DataFrame(index = strategy_list, columns=['study', 'almanac', 'label_x', 'label_y'])\n",
    "data['study'] = ipredict\n",
    "data['almanac'] = almanac\n",
    "data.fillna(0.0, inplace=True)\n",
    "\n",
    "data['study'] = data['study'].astype(int)\n",
    "data['almanac'] = data['almanac'].astype(int)\n",
    "\n",
    "data['label_x'] = data['study'] + numpy.random.rand(1)[0] - 0.5\n",
    "data['label_y'] = data['almanac'] + numpy.random.rand(1)[0] - 0.5\n",
    "\n",
    "data_b0 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Specific therapies"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "ipredict = therapies[~therapies['study-evidence-strongest'].isnull()]['therapy'].value_counts()\n",
    "almanac = therapies[~therapies['almanac-evidence-strongest'].isnull()]['therapy'].value_counts()\n",
    "therapies_list = therapies['therapy'].unique().tolist()\n",
    "\n",
    "data = pandas.DataFrame(index = therapies_list, columns=['study', 'almanac', 'label_x', 'label_y'])\n",
    "data['study'] = ipredict\n",
    "data['almanac'] = almanac\n",
    "data.fillna(0.0, inplace=True)\n",
    "\n",
    "data['study'] = data['study'].astype(int)\n",
    "data['almanac'] = data['almanac'].astype(int)\n",
    "\n",
    "data['label_x'] = data['study'] + numpy.random.rand(1)[0] - 0.5\n",
    "data['label_y'] = data['almanac'] + numpy.random.rand(1)[0] - 0.5\n",
    "\n",
    "data_b1 = data.copy(deep=True)\n",
    "data_b1.index = data_b1.index.str.capitalize()\n",
    "data_b1.rename(\n",
    "    index={'Amg 510': 'AMG 510', 'Pd-l1 antagonist': 'PD-L1', 'Epz015666': 'EPZ015666'},\n",
    "    inplace=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Molecular features targeted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "ipredict = features[features['ipredict_targeted'].eq(1)]['feature'].value_counts()\n",
    "almanac = features[features['sensitive_predictive_implication'].notnull()]['feature'].value_counts()\n",
    "features_list = features['feature'].sort_values().unique().tolist()\n",
    "\n",
    "data = pandas.DataFrame(index = features_list, columns=['study', 'almanac', 'label_x', 'label_y'])\n",
    "data['study'] = ipredict\n",
    "data['almanac'] = almanac\n",
    "\n",
    "data.rename(index={'CDKN2A': 'CDKN2A/B'}, inplace=True)\n",
    "data.drop('CDKN2B', inplace=True)\n",
    "data.fillna(0.0, inplace=True)\n",
    "\n",
    "data['study'] = data['study'].astype(int)\n",
    "data['almanac'] = data['almanac'].astype(int)\n",
    "\n",
    "data['label_x'] = data['study'] + numpy.random.rand(1)[0] - 0.5\n",
    "data['label_y'] = data['almanac'] + numpy.random.rand(1)[0] - 0.5\n",
    "\n",
    "data_b2 = data.copy(deep=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "study      4.000000\n",
       "almanac    5.000000\n",
       "label_x    3.956796\n",
       "label_y    4.602296\n",
       "Name: TMB-High, dtype: float64"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_b2.loc['TMB-High', :]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Generate figure"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "a0_replace_dict = {\n",
    "    'Citation listed not applicable': 'Citation listed\\nnot applicable',\n",
    "    'Not based on molecular features': 'Not based on\\nmolecular features'\n",
    "}\n",
    "\n",
    "b0_replace_dict = {\n",
    "    'targets KRAS G12C': 'targets\\nKRAS G12C'\n",
    "    \n",
    "}\n",
    "\n",
    "data_a0.rename(index=a0_replace_dict, inplace=True)\n",
    "data_b0.rename(index=b0_replace_dict, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x1080 with 5 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "font_size_legend = 15\n",
    "font_size_data = 16\n",
    "font_size_axis_label = 18\n",
    "font_size_tick_params = 18\n",
    "font_size_title_minor = 20\n",
    "font_size_title_major = 22\n",
    "\n",
    "figure = plt.figure(figsize=(20, 15), constrained_layout=True)\n",
    "gs = figure.add_gridspec(nrows=2, ncols=6)\n",
    "\n",
    "# ax2: Comparison of therapies (I-PREDICT) with unique and shared strategies per patient by evidence level\n",
    "ax2 = figure.add_subplot(gs[0, 0:3])\n",
    "p2 = data_a0.plot(kind='bar', color=[purple, blue], stacked=True, fontsize=font_size_data, rot=45, ax=ax2)\n",
    "label_by_height(data_a0, ax2)\n",
    "\n",
    "plt.tick_params(axis=\"both\", which=\"both\", \n",
    "                bottom=False, top=False, left=True, right=False,    \n",
    "                labelbottom=True, labeltop=False, labelleft=True, labelright=False) \n",
    "plt.xticks(horizontalalignment='right')\n",
    "plt.legend(frameon=False, fontsize=font_size_legend, loc=0)\n",
    "\n",
    "ax2_limit = 105 # roundup(data_a0.iloc[:, :2].sum(axis=1).max(), 5)\n",
    "ax2.set_ylim([-1, ax2_limit])\n",
    "\n",
    "value = therapies[therapies['study-evidence-strongest'].notnull()].shape[0]\n",
    "title = 'Therapies administered to patients in\\nI-PREDICT (n={}) by evidence'.format(value)\n",
    "ax2.set_title(title, fontsize=font_size_title_minor)\n",
    "\n",
    "# ax3: Comparison of therapies (MOAlmanac) with unique and shared strategies per patient by evidence level\n",
    "ax3 = figure.add_subplot(gs[0, 3:])\n",
    "p3 = data_a1.plot(kind='bar', color=[purple, red], stacked=True, fontsize=font_size_data, rot=45, ax=ax3)\n",
    "label_by_height(data_a1, ax3)\n",
    "\n",
    "plt.tick_params(axis=\"both\", which=\"both\", \n",
    "                bottom=False, top=False, left=True, right=False,    \n",
    "                labelbottom=True, labeltop=False, labelleft=True, labelright=False) \n",
    "plt.xticks(horizontalalignment='right')\n",
    "plt.legend(frameon=False, fontsize=font_size_legend, loc=2)\n",
    "\n",
    "ax3_limit = 105 # roundup(data_a1.iloc[:, :2].sum(axis=1).max(), 5)\n",
    "ax3.set_ylim([-1, ax3_limit])\n",
    "\n",
    "value = therapies[therapies['almanac-evidence-strongest'].notnull()].shape[0]\n",
    "title = 'Therapies highlighted by Molecular Oncology Almanac\\n(n={}) for I-PREDICT patients by evidence'.format(value)\n",
    "ax3.set_title(title, fontsize=font_size_title_minor)\n",
    "\n",
    "# ax4: Scatter of therapeutic strategies\n",
    "ax4 = figure.add_subplot(gs[1, :2])\n",
    "p4 = data_b0.plot(kind='scatter', x='study', y='almanac', s=100, alpha=0.75, ax=ax4, color=green)\n",
    "\n",
    "ax4_limit = 30 # roundup(int(max(data_b0['study'].max(), data_c0['almanac'].max())), 5)\n",
    "p4_line = plt.plot(range(0, ax4_limit), range(0, ax4_limit), linestyle='--', color='grey', alpha=0.33)\n",
    "\n",
    "#for idx in data_b0.index:\n",
    "#    display_label(data_b0, ax4, 9, 9, idx)\n",
    "    \n",
    "display_label(data_b0, ax4, 9, 9, 'targets\\nKRAS G12C', add_x=0, add_y=1)\n",
    "display_label(data_b0, ax4, 9, 9, 'PI3K/AKT/mTOR', add_x=-2, add_y=-2)\n",
    "display_label(data_b0, ax4, 9, 9, 'PRMT5', add_x=0, add_y=1)\n",
    "display_label(data_b0, ax4, 9, 9, 'CDK4/6', add_x=1, add_y=0)\n",
    "display_label(data_b0, ax4, 9, 9, 'PARP', add_x=0, add_y=1)\n",
    "display_label(data_b0, ax4, 9, 9, 'EGFR', add_x=1, add_y=-1)\n",
    "display_label(data_b0, ax4, 9, 9, 'MEK', add_x=1, add_y=0)\n",
    "display_label(data_b0, ax4, 9, 9, 'VEGF/VEGFR', add_x=-5, add_y=1)\n",
    "display_label(data_b0, ax4, 9, 9, 'PD-1/PD-L1', add_x=0, add_y=-2)\n",
    "display_label(data_b0, ax4, 9, 9, 'ER signaling', add_x=0, add_y=1)\n",
    "\n",
    "ax4.set_ylabel('Molecular Oncology Almanac\\n(# of patients)', fontsize = font_size_axis_label)\n",
    "ax4.set_xlabel('', fontsize = font_size_axis_label)\n",
    "ax4.set_ylim([-1, ax4_limit])\n",
    "ax4.set_xlim([-1, ax4_limit])\n",
    "ax4.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "\n",
    "title = 'Therapeutic strategies'\n",
    "ax4.set_title(title, fontsize = font_size_title_minor, y = 1.05)\n",
    "\n",
    "# ax5: Scatter of therapies\n",
    "ax5 = figure.add_subplot(gs[1, 2:4])\n",
    "p5 = data_b1.plot(kind='scatter', x='study', y='almanac', s=100, alpha=0.75, ax=ax5, color=green)\n",
    "\n",
    "ax5_limit = 30 # roundup(int(max(data_c1['study'].max(), data_c1['almanac'].max())), 5)\n",
    "p5_line = plt.plot(range(0, ax5_limit), range(0, ax5_limit), linestyle='--', color='grey', alpha=0.33)\n",
    "\n",
    "#for idx in data_b1.index:\n",
    "#    display_label(data_b1, ax5, 6, 6, idx)\n",
    "    \n",
    "display_label(data_b1, ax5, 6, 6, 'AMG 510', add_x=0, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Pictilisib', add_x=1, add_y=0)\n",
    "display_label(data_b1, ax5, 6, 6, 'EPZ015666', add_x=1, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Palbociclib', add_x=1, add_y=-1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Everolimus', add_x=1, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Trametinib', add_x=1, add_y=0)\n",
    "#display_label(data_b1, ax5, 6, 6, 'Nivolumab', add_x=1, add_y=1)\n",
    "display_label(data_b1, ax5, 6, 6, 'Pembrolizumab', add_x=1, add_y=1)\n",
    "\n",
    "ax5.set_ylabel('', fontsize = font_size_axis_label)\n",
    "ax5.set_xlabel('I-PREDICT (# of patients)', fontsize = font_size_axis_label)\n",
    "ax5.set_ylim([-1, ax5_limit])\n",
    "ax5.set_xlim([-1, ax5_limit])\n",
    "ax5.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "\n",
    "title = 'Therapies'\n",
    "ax5.set_title(title, fontsize = font_size_title_minor, y = 1.05)\n",
    "\n",
    "# ax6: Scatter of features\n",
    "ax6 = figure.add_subplot(gs[1, 4:])\n",
    "p6 = data_b2.plot(kind='scatter', x='study', y='almanac', s=100, alpha=0.75, ax=ax6, color=orange)\n",
    "\n",
    "ax6_limit = 30 #roundup(int(max(data_b2['study'].max(), data_b2['almanac'].max())), 5)\n",
    "p6_line = plt.plot(range(0, ax6_limit), range(0, ax6_limit), linestyle='--', color='grey', alpha=0.33)\n",
    "\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'ATM', add_x=0, add_y=1)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'EGFR', add_x=1, add_y=0)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'CDKN2A/B', add_x=-1, add_y=1)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'PIK3CA', add_x=-4, add_y=1)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'KRAS', add_x=1, add_y=0)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'ERBB2', add_x=1, add_y=0)\n",
    "display_label(data_b2, ax6, 7.5, 7.5, 'TP53', add_x=0, add_y=1.5)\n",
    "display_label(data_b2, ax6, 0, 0, 'TMB-Int', add_x=1, add_y=0)\n",
    "\n",
    "ax6.set_ylabel('', fontsize = font_size_axis_label)\n",
    "ax6.set_xlabel('', fontsize = font_size_axis_label)\n",
    "ax6.set_ylim([-1, ax6_limit])\n",
    "ax6.set_xlim([-1, ax6_limit])\n",
    "ax6.tick_params(axis='both', which='major', labelsize = font_size_tick_params)\n",
    "\n",
    "title = 'Genes & molecular features'\n",
    "ax6.set_title(title, fontsize=font_size_title_minor, y = 1.05)\n",
    "\n",
    "for ax in [ax2, ax3, ax4, ax5, ax6]:\n",
    "    remove_spines(ax)\n",
    "    \n",
    "fig_label_x = 0.01\n",
    "fig_label_y_a = 0.98\n",
    "fig_label_y_b = 0.45\n",
    "font_size_lg = 25\n",
    "\n",
    "plt.figtext(fig_label_x, fig_label_y_a, 'a', fontsize=font_size_lg)\n",
    "plt.figtext(fig_label_x, fig_label_y_b, 'b', fontsize=font_size_lg)\n",
    "\n",
    "folder_name = '../../figures/figure-04'\n",
    "file_name = 'figure-4'\n",
    "!mkdir -p $folder_name\n",
    "for suffix in ['svg', 'png', 'pdf']:\n",
    "    outname = f'{folder_name}/{file_name}.{suffix}'\n",
    "    plt.savefig(outname, format=suffix)\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import openpyxl\n",
    "with pd.ExcelWriter(f'{folder_name}/{file_name}.xlsx') as writer:  \n",
    "    data_a0.to_excel(writer, sheet_name='figure 4a - ipredict', index_label='Evidence')\n",
    "    data_a1.to_excel(writer, sheet_name='figure 4a - moalmanac', index_label='Evidence')\n",
    "    data_b0.to_excel(writer, sheet_name='figure 4b - strategies', index_label='Strategy')\n",
    "    data_b1.to_excel(writer, sheet_name='figure 4b - therapies', index_label='Therapy')\n",
    "    data_b2.to_excel(writer, sheet_name='figure 4b - genes and features', index_label='Gene or molecular feature')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary\n",
    "1. What strategies are shared and not shared?\n",
    "2. How many patients do we observe a shared therapeutic strategy?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### What items are shared or not shared?\n",
    "1. The most common shared strategies are PI3K/AKT/mTOR inhibition and HER2 inhibition, followed by immunotherapy. \n",
    "2. I-PREDICT favors VEGF/VEGFR inhibition by targeting TP53 variants\n",
    "3. Molecular Oncology Almanac commonly recommends PRMT5 based on CDKN2A/B loss\n",
    "\n",
    "There is likely opportunity to note, perhaps in the discussion, that there is variability as to how the two approaches arrive at the same therapeutic strategy. For example, PI3K/AKT/mTOR us recommended more recent HER2 inhibitors."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "PI3K/AKT/mTOR    9\n",
       "ER signaling     9\n",
       "PD-1/PD-L1       8\n",
       "EGFR             5\n",
       "CDK4/6           4\n",
       "MET              4\n",
       "BRAF             3\n",
       "MEK              3\n",
       "PARP             2\n",
       "RET              1\n",
       "Chemotherapy     1\n",
       "Name: strategy, dtype: int64"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "idx_shared = therapies['included-in-overlapping-strategy'].eq(1)\n",
    "idx_almanac = therapies['almanac-evidence-strongest'].notnull()\n",
    "idx_study = therapies['study-evidence-strongest'].notnull()\n",
    "\n",
    "therapies[idx_shared].loc[:, ['patient_id', 'strategy']].drop_duplicates()['strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "VEGF/VEGFR         25\n",
       "MEK                13\n",
       "PD-1/PD-L1         10\n",
       "NSAID               5\n",
       "ER signaling        5\n",
       "PI3K/AKT/mTOR       5\n",
       "PARP                3\n",
       "CDK4/6              3\n",
       "Antineoplastic      2\n",
       "Chemotherapy        2\n",
       "EGFR                2\n",
       "MET                 1\n",
       "RANKL               1\n",
       "IGF                 1\n",
       "Wee-1               1\n",
       "Hedgehog            1\n",
       "OX40 antagonist     1\n",
       "ALK                 1\n",
       "targets BCR-ABL     1\n",
       "BET                 1\n",
       "Name: strategy, dtype: int64"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[~idx_shared & idx_study].loc[:, ['patient_id', 'strategy']].drop_duplicates()['strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "targets KRAS G12C                     19\n",
       "PI3K/AKT/mTOR                         14\n",
       "PRMT5                                 13\n",
       "PARP                                   8\n",
       "FGFR                                   8\n",
       "MDM2-p53                               7\n",
       "CDK4/6                                 6\n",
       "PD-1/PD-L1                             5\n",
       "Proteasome                             5\n",
       "ATR                                    5\n",
       "Aurora kinase                          4\n",
       "BRAF                                   2\n",
       "ER signaling                           2\n",
       "Chemotherapy                           2\n",
       "EGFR                                   2\n",
       "IDH1                                   1\n",
       "Hypomethylating agent chemotherapy     1\n",
       "ALK                                    1\n",
       "targets BCR-ABL                        1\n",
       "IDH2                                   1\n",
       "MEK                                    1\n",
       "JAK                                    1\n",
       "Name: strategy, dtype: int64"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[~idx_shared & idx_almanac].loc[:, ['patient_id', 'strategy']].drop_duplicates()['strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "pictilisib    17\n",
       "azd8186        4\n",
       "mk-2206        3\n",
       "everolimus     3\n",
       "alpelisib      1\n",
       "sirolimus      1\n",
       "Name: therapy, dtype: int64"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[idx_almanac & therapies['strategy'].eq('PI3K/AKT/mTOR')]['therapy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "      <th>almanac_top_recommendation_group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>34</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>73</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>101</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>102</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>119</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id    therapy study-evidence-strongest almanac-evidence-strongest  \\\n",
       "40          34  epz015666                      NaN                Preclinical   \n",
       "83          73  epz015666                      NaN                Preclinical   \n",
       "116        101  epz015666                      NaN                Preclinical   \n",
       "119        102  epz015666                      NaN                Preclinical   \n",
       "138        119  epz015666                      NaN                Preclinical   \n",
       "\n",
       "     included-in-overlapping-strategy strategy  study-gave-as-matched-therapy  \\\n",
       "40                                  0    PRMT5                            NaN   \n",
       "83                                  0    PRMT5                            NaN   \n",
       "116                                 0    PRMT5                            NaN   \n",
       "119                                 0    PRMT5                            NaN   \n",
       "138                                 0    PRMT5                            NaN   \n",
       "\n",
       "    study-citations-used-for-patient comment-on-study-citation substrategy  \\\n",
       "40                               NaN                       NaN         NaN   \n",
       "83                               NaN                       NaN         NaN   \n",
       "116                              NaN                       NaN         NaN   \n",
       "119                              NaN                       NaN         NaN   \n",
       "138                              NaN                       NaN         NaN   \n",
       "\n",
       "     almanac_top_recommendation_group  \n",
       "40                                0.0  \n",
       "83                                0.0  \n",
       "116                               1.0  \n",
       "119                               1.0  \n",
       "138                               1.0  "
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[therapies['strategy'].eq('PRMT5')].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "53     CDKN2A\n",
       "149    CDKN2A\n",
       "190    CDKN2A\n",
       "195    CDKN2A\n",
       "228    CDKN2A\n",
       "Name: feature, dtype: object"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "features[features['sensitive_therapy_name'].eq('EPZ015666')]['feature'].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(18,)\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>feature</th>\n",
       "      <th>feature_type</th>\n",
       "      <th>alteration_type</th>\n",
       "      <th>alteration</th>\n",
       "      <th>patient_id</th>\n",
       "      <th>ipredict_targeted</th>\n",
       "      <th>score_bin</th>\n",
       "      <th>sensitive_predictive_implication</th>\n",
       "      <th>resistance_predictive_implication</th>\n",
       "      <th>prognostic_predictive_implication</th>\n",
       "      <th>...</th>\n",
       "      <th>resistance_therapy_strategy</th>\n",
       "      <th>resistance_therapy_type</th>\n",
       "      <th>resistance_description</th>\n",
       "      <th>resistance_citation</th>\n",
       "      <th>resistance_url</th>\n",
       "      <th>prognostic_score_bin</th>\n",
       "      <th>favorable_prognosis</th>\n",
       "      <th>prognostic_description</th>\n",
       "      <th>prognostic_citation</th>\n",
       "      <th>prognostic_url</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R248Q</td>\n",
       "      <td>9</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunomodulation</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Nonsense</td>\n",
       "      <td>p.R306*</td>\n",
       "      <td>20</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunomodulation</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Mutations in TP53 correlated with shorter over...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R175H</td>\n",
       "      <td>34</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunomodulation</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.R282W</td>\n",
       "      <td>39</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunomodulation</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>TP53</td>\n",
       "      <td>Somatic Variant</td>\n",
       "      <td>Missense</td>\n",
       "      <td>p.V157F</td>\n",
       "      <td>48</td>\n",
       "      <td>1</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>...</td>\n",
       "      <td>Immunomodulation</td>\n",
       "      <td>Targeted therapy</td>\n",
       "      <td>More frequent with complex karyotypes and del(...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "      <td>Investigate Actionability</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Missense mutation in any codon except P47S or ...</td>\n",
       "      <td>National Comprehensive Cancer Network. Myelody...</td>\n",
       "      <td>https://www.nccn.org/professionals/physician_g...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows  29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    feature     feature_type alteration_type alteration patient_id  \\\n",
       "9      TP53  Somatic Variant        Missense    p.R248Q          9   \n",
       "20     TP53  Somatic Variant        Nonsense    p.R306*         20   \n",
       "59     TP53  Somatic Variant        Missense    p.R175H         34   \n",
       "67     TP53  Somatic Variant        Missense    p.R282W         39   \n",
       "106    TP53  Somatic Variant        Missense    p.V157F         48   \n",
       "\n",
       "     ipredict_targeted                  score_bin  \\\n",
       "9                    1  Investigate Actionability   \n",
       "20                   1  Investigate Actionability   \n",
       "59                   1  Investigate Actionability   \n",
       "67                   1  Investigate Actionability   \n",
       "106                  1  Investigate Actionability   \n",
       "\n",
       "    sensitive_predictive_implication resistance_predictive_implication  \\\n",
       "9                                NaN                         Guideline   \n",
       "20                               NaN                         Guideline   \n",
       "59                               NaN                         Guideline   \n",
       "67                               NaN                         Guideline   \n",
       "106                              NaN                         Guideline   \n",
       "\n",
       "    prognostic_predictive_implication  ... resistance_therapy_strategy  \\\n",
       "9                           Guideline  ...            Immunomodulation   \n",
       "20                          Guideline  ...            Immunomodulation   \n",
       "59                          Guideline  ...            Immunomodulation   \n",
       "67                          Guideline  ...            Immunomodulation   \n",
       "106                         Guideline  ...            Immunomodulation   \n",
       "\n",
       "    resistance_therapy_type  \\\n",
       "9          Targeted therapy   \n",
       "20         Targeted therapy   \n",
       "59         Targeted therapy   \n",
       "67         Targeted therapy   \n",
       "106        Targeted therapy   \n",
       "\n",
       "                                resistance_description  \\\n",
       "9    More frequent with complex karyotypes and del(...   \n",
       "20   More frequent with complex karyotypes and del(...   \n",
       "59   More frequent with complex karyotypes and del(...   \n",
       "67   More frequent with complex karyotypes and del(...   \n",
       "106  More frequent with complex karyotypes and del(...   \n",
       "\n",
       "                                   resistance_citation  \\\n",
       "9    National Comprehensive Cancer Network. Myelody...   \n",
       "20   National Comprehensive Cancer Network. Myelody...   \n",
       "59   National Comprehensive Cancer Network. Myelody...   \n",
       "67   National Comprehensive Cancer Network. Myelody...   \n",
       "106  National Comprehensive Cancer Network. Myelody...   \n",
       "\n",
       "                                        resistance_url  \\\n",
       "9    https://www.nccn.org/professionals/physician_g...   \n",
       "20   https://www.nccn.org/professionals/physician_g...   \n",
       "59   https://www.nccn.org/professionals/physician_g...   \n",
       "67   https://www.nccn.org/professionals/physician_g...   \n",
       "106  https://www.nccn.org/professionals/physician_g...   \n",
       "\n",
       "          prognostic_score_bin favorable_prognosis  \\\n",
       "9    Investigate Actionability                 0.0   \n",
       "20   Investigate Actionability                 0.0   \n",
       "59   Investigate Actionability                 0.0   \n",
       "67   Investigate Actionability                 0.0   \n",
       "106  Investigate Actionability                 0.0   \n",
       "\n",
       "                                prognostic_description  \\\n",
       "9    Missense mutation in any codon except P47S or ...   \n",
       "20   Mutations in TP53 correlated with shorter over...   \n",
       "59   Missense mutation in any codon except P47S or ...   \n",
       "67   Missense mutation in any codon except P47S or ...   \n",
       "106  Missense mutation in any codon except P47S or ...   \n",
       "\n",
       "                                   prognostic_citation  \\\n",
       "9    National Comprehensive Cancer Network. Myelody...   \n",
       "20   National Comprehensive Cancer Network. Myelody...   \n",
       "59   National Comprehensive Cancer Network. Myelody...   \n",
       "67   National Comprehensive Cancer Network. Myelody...   \n",
       "106  National Comprehensive Cancer Network. Myelody...   \n",
       "\n",
       "                                        prognostic_url  \n",
       "9    https://www.nccn.org/professionals/physician_g...  \n",
       "20   https://www.nccn.org/professionals/physician_g...  \n",
       "59   https://www.nccn.org/professionals/physician_g...  \n",
       "67   https://www.nccn.org/professionals/physician_g...  \n",
       "106  https://www.nccn.org/professionals/physician_g...  \n",
       "\n",
       "[5 rows x 29 columns]"
      ]
     },
     "execution_count": 97,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vegf_patients = therapies[therapies['strategy'].eq('VEGF/VEGFR')]['patient_id'].astype(str).tolist()\n",
    "tp53_vegf = features[features['feature'].eq('TP53') & features['ipredict_targeted'].eq(1) & features['patient_id'].astype(str).isin(vegf_patients)]\n",
    "print(tp53_vegf['patient_id'].drop_duplicates().shape)\n",
    "print('')\n",
    "tp53_vegf.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### How many patients observe a shared therapeutic strategy?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(39,)"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Number of patients with overlapping strategies\n",
    "therapies[idx_shared]['patient_id'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(83,)"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Total N patients\n",
    "therapies['patient_id'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.46987951807228917"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# % of patients with overlapping strategies\n",
    "therapies[idx_shared]['patient_id'].drop_duplicates().shape[0] / therapies['patient_id'].drop_duplicates().shape[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(45,)"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Number of drugs in I-PREDICT\n",
    "therapies.loc[therapies['study-evidence-strongest'].dropna().index, 'therapy'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(40,)"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Number of drugs MOAlmanac\n",
    "therapies.loc[therapies['almanac-evidence-strongest'].dropna().index, 'therapy'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(33,)"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Number of strategies\n",
    "therapies['strategy'].dropna().drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(31,)"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Number of patients with a MOAlmanac therapy involved in overlapping strategy\n",
    "# being in the highest prioritized group highlighted \n",
    "therapies.loc[therapies['included-in-overlapping-strategy'].eq(1) & therapies['almanac_top_recommendation_group'], 'patient_id'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(35,)"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## Patients with FDA or guideline association by MOAlmanac that were not involved in an overlapping strategy\n",
    "idx_standard = therapies['almanac-evidence-strongest'].fillna('').isin(['FDA-Approved', 'Guideline'])\n",
    "idx_overlap = therapies['included-in-overlapping-strategy'].fillna(-1).eq(1)\n",
    "therapies.loc[idx_standard, 'patient_id'].drop_duplicates().shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(10,)\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "Index(['112', '34', '51', '53', '66', '89', '97', 'A037', 'A040', 'A042'], dtype='object', name='patient_id')"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "patients_std = therapies.loc[idx_standard, 'patient_id'].drop_duplicates()\n",
    "patients_std_overlap = therapies.loc[idx_standard & idx_overlap, 'patient_id'].drop_duplicates()\n",
    "patients_std_not_overlap = pd.Index(patients_std).difference(pd.Index(patients_std_overlap))\n",
    "print(patients_std_not_overlap.shape)\n",
    "patients_std_not_overlap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "      <th>almanac_top_recommendation_group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>34</td>\n",
       "      <td>lenvatinib</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6,16,17</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>34</td>\n",
       "      <td>nivolumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>34</td>\n",
       "      <td>pembrolizumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>34</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>34</td>\n",
       "      <td>erdafitinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>FGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>34</td>\n",
       "      <td>niraparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PARP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>34</td>\n",
       "      <td>neratinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>0</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>51</td>\n",
       "      <td>lenvatinib</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>16,17,19</td>\n",
       "      <td>Citations 16, 17 look at lenvatinib in particu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>51</td>\n",
       "      <td>olaparib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PARP</td>\n",
       "      <td>1.0</td>\n",
       "      <td>16,17,19</td>\n",
       "      <td>Citation 19 is a review focused on olaparib fo...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>51</td>\n",
       "      <td>pembrolizumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>51</td>\n",
       "      <td>alpelisib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>51</td>\n",
       "      <td>nutlin-3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>MDM2-p53</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>53</td>\n",
       "      <td>olaparib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PARP</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19,20,21</td>\n",
       "      <td>Citation 19 is a review focused on olaparib fo...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>53</td>\n",
       "      <td>sulindac</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>NSAID</td>\n",
       "      <td>1.0</td>\n",
       "      <td>19,20,21</td>\n",
       "      <td>Citation 21 looks at overall response of sulin...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>53</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>0</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>53</td>\n",
       "      <td>bay 1895344</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>ATR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>53</td>\n",
       "      <td>nutlin-3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>MDM2-p53</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>66</td>\n",
       "      <td>everolimus</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6,16,17,23</td>\n",
       "      <td>Citation 23 is a review of targeting PI3K/AKT/...</td>\n",
       "      <td>mtor</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>66</td>\n",
       "      <td>lenvatinib</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2,5,6,16,17,23</td>\n",
       "      <td>Citation 5 is a trial that looks at p53 status...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>66</td>\n",
       "      <td>olaparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PARP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>66</td>\n",
       "      <td>pictilisib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>1</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>pi3k</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>66</td>\n",
       "      <td>infigratinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>FGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>89</td>\n",
       "      <td>lenvatinib</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>16,17</td>\n",
       "      <td>Citations 16, 17 look at the efficacy lenvatin...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>89</td>\n",
       "      <td>pemigatinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>FGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>89</td>\n",
       "      <td>pembrolizumab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inferential</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>97</td>\n",
       "      <td>ceritinib</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>ALK</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>97</td>\n",
       "      <td>dasatinib</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>targets BCR-ABL</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>97</td>\n",
       "      <td>olaparib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>PARP</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>112</td>\n",
       "      <td>pembrolizumab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>18</td>\n",
       "      <td>Citation 18 covers a trial of 151 patients rec...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>112</td>\n",
       "      <td>bosutinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>targets BCR-ABL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>112</td>\n",
       "      <td>bortezomib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>Proteasome</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>A037</td>\n",
       "      <td>nivolumab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>PD-1/PD-L1</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4,18</td>\n",
       "      <td>Citation 18 covers a trial of 151 patients rec...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>268</th>\n",
       "      <td>A037</td>\n",
       "      <td>trametinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>MEK</td>\n",
       "      <td>1.0</td>\n",
       "      <td>4,18</td>\n",
       "      <td>Citation 4 describes targeting KRAS indirectly...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>269</th>\n",
       "      <td>A037</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>A037</td>\n",
       "      <td>azacitidine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>0</td>\n",
       "      <td>Hypomethylating agent chemotherapy</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271</th>\n",
       "      <td>A037</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>A040</td>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>A040</td>\n",
       "      <td>gefitinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>0</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>A040</td>\n",
       "      <td>osimertinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>A042</td>\n",
       "      <td>irinotecan</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Antineoplastic</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>A042</td>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>A042</td>\n",
       "      <td>denosumab</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>RANKL</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>A042</td>\n",
       "      <td>bay 1895344</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>ATR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>A042</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>A042</td>\n",
       "      <td>encorafenib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>0</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id        therapy         study-evidence-strongest  \\\n",
       "37          34     lenvatinib                      Preclinical   \n",
       "38          34     nivolumab                               NaN   \n",
       "39          34  pembrolizumab                              NaN   \n",
       "40          34      epz015666                              NaN   \n",
       "41          34    erdafitinib                              NaN   \n",
       "42          34      niraparib                              NaN   \n",
       "43          34      neratinib                              NaN   \n",
       "58          51     lenvatinib                      Preclinical   \n",
       "59          51       olaparib                   Clinical trial   \n",
       "60          51  pembrolizumab                              NaN   \n",
       "61          51      alpelisib                              NaN   \n",
       "62          51       nutlin-3                              NaN   \n",
       "63          53       olaparib                   Clinical trial   \n",
       "64          53       sulindac                      Preclinical   \n",
       "65          53    palbociclib                              NaN   \n",
       "66          53    bay 1895344                              NaN   \n",
       "67          53       nutlin-3                              NaN   \n",
       "73          66     everolimus                   Clinical trial   \n",
       "74          66     lenvatinib                      Preclinical   \n",
       "75          66       olaparib                              NaN   \n",
       "76          66     pictilisib                              NaN   \n",
       "77          66   infigratinib                              NaN   \n",
       "97          89     lenvatinib                      Preclinical   \n",
       "98          89    pemigatinib                              NaN   \n",
       "99          89  pembrolizumab                              NaN   \n",
       "107         97      ceritinib  Not based on molecular features   \n",
       "108         97      dasatinib  Not based on molecular features   \n",
       "109         97       olaparib                              NaN   \n",
       "125        112  pembrolizumab                   Clinical trial   \n",
       "126        112      bosutinib                              NaN   \n",
       "127        112     bortezomib                              NaN   \n",
       "267       A037      nivolumab                   Clinical trial   \n",
       "268       A037     trametinib                   Clinical trial   \n",
       "269       A037      epz015666                              NaN   \n",
       "270       A037    azacitidine                              NaN   \n",
       "271       A037        amg 510                              NaN   \n",
       "274       A040    bevacizumab  Not based on molecular features   \n",
       "275       A040      gefitinib                              NaN   \n",
       "276       A040    osimertinib                              NaN   \n",
       "281       A042     irinotecan  Not based on molecular features   \n",
       "282       A042    bevacizumab  Not based on molecular features   \n",
       "283       A042      denosumab  Not based on molecular features   \n",
       "284       A042    bay 1895344                              NaN   \n",
       "285       A042      cetuximab                              NaN   \n",
       "286       A042    encorafenib                              NaN   \n",
       "\n",
       "    almanac-evidence-strongest  included-in-overlapping-strategy  \\\n",
       "37                         NaN                                 0   \n",
       "38           Clinical evidence                                 0   \n",
       "39           Clinical evidence                                 0   \n",
       "40                 Preclinical                                 0   \n",
       "41                FDA-Approved                                 0   \n",
       "42                FDA-Approved                                 0   \n",
       "43           Clinical evidence                                 0   \n",
       "58                         NaN                                 0   \n",
       "59                FDA-Approved                                 0   \n",
       "60                FDA-Approved                                 0   \n",
       "61                FDA-Approved                                 0   \n",
       "62                 Preclinical                                 0   \n",
       "63                         NaN                                 0   \n",
       "64                         NaN                                 0   \n",
       "65                   Guideline                                 0   \n",
       "66              Clinical trial                                 0   \n",
       "67                 Preclinical                                 0   \n",
       "73                         NaN                                 1   \n",
       "74                         NaN                                 0   \n",
       "75                FDA-Approved                                 0   \n",
       "76              Clinical trial                                 1   \n",
       "77                 Preclinical                                 0   \n",
       "97                         NaN                                 0   \n",
       "98                FDA-Approved                                 0   \n",
       "99                 Inferential                                 0   \n",
       "107                        NaN                                 0   \n",
       "108                        NaN                                 0   \n",
       "109               FDA-Approved                                 0   \n",
       "125                        NaN                                 0   \n",
       "126               FDA-Approved                                 0   \n",
       "127                Preclinical                                 0   \n",
       "267                        NaN                                 0   \n",
       "268                        NaN                                 0   \n",
       "269                Preclinical                                 0   \n",
       "270                  Guideline                                 0   \n",
       "271             Clinical trial                                 0   \n",
       "274                        NaN                                 0   \n",
       "275          Clinical evidence                                 0   \n",
       "276               FDA-Approved                                 0   \n",
       "281                        NaN                                 0   \n",
       "282                        NaN                                 0   \n",
       "283                        NaN                                 0   \n",
       "284             Clinical trial                                 0   \n",
       "285               FDA-Approved                                 0   \n",
       "286               FDA-Approved                                 0   \n",
       "\n",
       "                               strategy  study-gave-as-matched-therapy  \\\n",
       "37                           VEGF/VEGFR                            1.0   \n",
       "38                           PD-1/PD-L1                            NaN   \n",
       "39                           PD-1/PD-L1                            NaN   \n",
       "40                                PRMT5                            NaN   \n",
       "41                                 FGFR                            NaN   \n",
       "42                                 PARP                            NaN   \n",
       "43                         ER signaling                            NaN   \n",
       "58                           VEGF/VEGFR                            1.0   \n",
       "59                                 PARP                            1.0   \n",
       "60                           PD-1/PD-L1                            NaN   \n",
       "61                        PI3K/AKT/mTOR                            NaN   \n",
       "62                             MDM2-p53                            NaN   \n",
       "63                                 PARP                            1.0   \n",
       "64                                NSAID                            1.0   \n",
       "65                               CDK4/6                            NaN   \n",
       "66                                  ATR                            NaN   \n",
       "67                             MDM2-p53                            NaN   \n",
       "73                        PI3K/AKT/mTOR                            1.0   \n",
       "74                           VEGF/VEGFR                            1.0   \n",
       "75                                 PARP                            NaN   \n",
       "76                        PI3K/AKT/mTOR                            NaN   \n",
       "77                                 FGFR                            NaN   \n",
       "97                           VEGF/VEGFR                            1.0   \n",
       "98                                 FGFR                            NaN   \n",
       "99                           PD-1/PD-L1                            NaN   \n",
       "107                                 ALK                            0.0   \n",
       "108                     targets BCR-ABL                            0.0   \n",
       "109                                PARP                            NaN   \n",
       "125                          PD-1/PD-L1                            1.0   \n",
       "126                     targets BCR-ABL                            NaN   \n",
       "127                          Proteasome                            NaN   \n",
       "267                          PD-1/PD-L1                            1.0   \n",
       "268                                 MEK                            1.0   \n",
       "269                               PRMT5                            NaN   \n",
       "270  Hypomethylating agent chemotherapy                            NaN   \n",
       "271                   targets KRAS G12C                            NaN   \n",
       "274                          VEGF/VEGFR                            0.0   \n",
       "275                                EGFR                            NaN   \n",
       "276                                EGFR                            NaN   \n",
       "281                      Antineoplastic                            0.0   \n",
       "282                          VEGF/VEGFR                            0.0   \n",
       "283                               RANKL                            0.0   \n",
       "284                                 ATR                            NaN   \n",
       "285                                EGFR                            NaN   \n",
       "286                                BRAF                            NaN   \n",
       "\n",
       "    study-citations-used-for-patient  \\\n",
       "37                       2,5,6,16,17   \n",
       "38                               NaN   \n",
       "39                               NaN   \n",
       "40                               NaN   \n",
       "41                               NaN   \n",
       "42                               NaN   \n",
       "43                               NaN   \n",
       "58                          16,17,19   \n",
       "59                          16,17,19   \n",
       "60                               NaN   \n",
       "61                               NaN   \n",
       "62                               NaN   \n",
       "63                          19,20,21   \n",
       "64                          19,20,21   \n",
       "65                               NaN   \n",
       "66                               NaN   \n",
       "67                               NaN   \n",
       "73                    2,5,6,16,17,23   \n",
       "74                    2,5,6,16,17,23   \n",
       "75                               NaN   \n",
       "76                               NaN   \n",
       "77                               NaN   \n",
       "97                             16,17   \n",
       "98                               NaN   \n",
       "99                               NaN   \n",
       "107                   Not applicable   \n",
       "108                   Not applicable   \n",
       "109                              NaN   \n",
       "125                               18   \n",
       "126                              NaN   \n",
       "127                              NaN   \n",
       "267                             4,18   \n",
       "268                             4,18   \n",
       "269                              NaN   \n",
       "270                              NaN   \n",
       "271                              NaN   \n",
       "274                   Not applicable   \n",
       "275                              NaN   \n",
       "276                              NaN   \n",
       "281                   Not applicable   \n",
       "282                   Not applicable   \n",
       "283                   Not applicable   \n",
       "284                              NaN   \n",
       "285                              NaN   \n",
       "286                              NaN   \n",
       "\n",
       "                             comment-on-study-citation substrategy  \\\n",
       "37                                          VEGF/VEGFR         NaN   \n",
       "38                                                 NaN         NaN   \n",
       "39                                                 NaN         NaN   \n",
       "40                                                 NaN         NaN   \n",
       "41                                                 NaN         NaN   \n",
       "42                                                 NaN         NaN   \n",
       "43                                                 NaN         NaN   \n",
       "58   Citations 16, 17 look at lenvatinib in particu...         NaN   \n",
       "59   Citation 19 is a review focused on olaparib fo...         NaN   \n",
       "60                                                 NaN         NaN   \n",
       "61                                                 NaN         NaN   \n",
       "62                                                 NaN         NaN   \n",
       "63   Citation 19 is a review focused on olaparib fo...         NaN   \n",
       "64   Citation 21 looks at overall response of sulin...         NaN   \n",
       "65                                                 NaN         NaN   \n",
       "66                                                 NaN         NaN   \n",
       "67                                                 NaN         NaN   \n",
       "73   Citation 23 is a review of targeting PI3K/AKT/...        mtor   \n",
       "74   Citation 5 is a trial that looks at p53 status...         NaN   \n",
       "75                                                 NaN         NaN   \n",
       "76                                                 NaN        pi3k   \n",
       "77                                                 NaN         NaN   \n",
       "97   Citations 16, 17 look at the efficacy lenvatin...         NaN   \n",
       "98                                                 NaN         NaN   \n",
       "99                                                 NaN         NaN   \n",
       "107                                                NaN         NaN   \n",
       "108                                                NaN         NaN   \n",
       "109                                                NaN         NaN   \n",
       "125  Citation 18 covers a trial of 151 patients rec...         NaN   \n",
       "126                                                NaN         NaN   \n",
       "127                                                NaN         NaN   \n",
       "267  Citation 18 covers a trial of 151 patients rec...         NaN   \n",
       "268  Citation 4 describes targeting KRAS indirectly...         NaN   \n",
       "269                                                NaN         NaN   \n",
       "270                                                NaN         NaN   \n",
       "271                                                NaN         NaN   \n",
       "274                                                NaN         NaN   \n",
       "275                                                NaN         NaN   \n",
       "276                                                NaN         NaN   \n",
       "281                                                NaN         NaN   \n",
       "282                                                NaN         NaN   \n",
       "283                                                NaN         NaN   \n",
       "284                                                NaN         NaN   \n",
       "285                                                NaN         NaN   \n",
       "286                                                NaN         NaN   \n",
       "\n",
       "     almanac_top_recommendation_group  \n",
       "37                                NaN  \n",
       "38                                0.0  \n",
       "39                                0.0  \n",
       "40                                0.0  \n",
       "41                                1.0  \n",
       "42                                0.0  \n",
       "43                                0.0  \n",
       "58                                NaN  \n",
       "59                                1.0  \n",
       "60                                1.0  \n",
       "61                                1.0  \n",
       "62                                0.0  \n",
       "63                                NaN  \n",
       "64                                NaN  \n",
       "65                                1.0  \n",
       "66                                0.0  \n",
       "67                                0.0  \n",
       "73                                NaN  \n",
       "74                                NaN  \n",
       "75                                1.0  \n",
       "76                                0.0  \n",
       "77                                0.0  \n",
       "97                                NaN  \n",
       "98                                1.0  \n",
       "99                                0.0  \n",
       "107                               NaN  \n",
       "108                               NaN  \n",
       "109                               1.0  \n",
       "125                               NaN  \n",
       "126                               1.0  \n",
       "127                               0.0  \n",
       "267                               NaN  \n",
       "268                               NaN  \n",
       "269                               0.0  \n",
       "270                               1.0  \n",
       "271                               0.0  \n",
       "274                               NaN  \n",
       "275                               0.0  \n",
       "276                               1.0  \n",
       "281                               NaN  \n",
       "282                               NaN  \n",
       "283                               NaN  \n",
       "284                               0.0  \n",
       "285                               1.0  \n",
       "286                               1.0  "
      ]
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[therapies['patient_id'].isin(patients_std_not_overlap)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "non_standard = therapies[~(therapies['almanac-evidence-strongest'].fillna('').isin(['FDA-Approved', 'Guideline', '']))]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    94\n",
       "1    27\n",
       "Name: included-in-overlapping-strategy, dtype: int64"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard_counts = non_standard['included-in-overlapping-strategy'].value_counts()\n",
    "non_standard_counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    0.77686\n",
       "1    0.22314\n",
       "Name: included-in-overlapping-strategy, dtype: float64"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard_counts.divide(non_standard_counts.sum())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "121"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard_counts.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "      <th>almanac_top_recommendation_group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5</td>\n",
       "      <td>nutlin-3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>MDM2-p53</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>7</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>9</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>15</td>\n",
       "      <td>nutlin-3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>MDM2-p53</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>19</td>\n",
       "      <td>pictilisib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>A043</td>\n",
       "      <td>neratinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TKI</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>A043</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>A044</td>\n",
       "      <td>everolimus</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical evidence</td>\n",
       "      <td>0</td>\n",
       "      <td>PI3K/AKT/mTOR</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>A045</td>\n",
       "      <td>amg 510</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>0</td>\n",
       "      <td>targets KRAS G12C</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>A045</td>\n",
       "      <td>epz015666</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>0</td>\n",
       "      <td>PRMT5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>121 rows  11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id     therapy study-evidence-strongest  \\\n",
       "2            5    nutlin-3                      NaN   \n",
       "5            7     amg 510                      NaN   \n",
       "7            9     amg 510                      NaN   \n",
       "9           15    nutlin-3                      NaN   \n",
       "11          19  pictilisib                      NaN   \n",
       "..         ...         ...                      ...   \n",
       "290       A043   neratinib                      NaN   \n",
       "291       A043     amg 510                      NaN   \n",
       "295       A044  everolimus                      NaN   \n",
       "298       A045     amg 510                      NaN   \n",
       "299       A045   epz015666                      NaN   \n",
       "\n",
       "    almanac-evidence-strongest  included-in-overlapping-strategy  \\\n",
       "2                  Preclinical                                 0   \n",
       "5               Clinical trial                                 0   \n",
       "7               Clinical trial                                 0   \n",
       "9                  Preclinical                                 0   \n",
       "11                 Preclinical                                 0   \n",
       "..                         ...                               ...   \n",
       "290          Clinical evidence                                 1   \n",
       "291             Clinical trial                                 0   \n",
       "295          Clinical evidence                                 0   \n",
       "298             Clinical trial                                 0   \n",
       "299                Preclinical                                 0   \n",
       "\n",
       "              strategy  study-gave-as-matched-therapy  \\\n",
       "2             MDM2-p53                            NaN   \n",
       "5    targets KRAS G12C                            NaN   \n",
       "7    targets KRAS G12C                            NaN   \n",
       "9             MDM2-p53                            NaN   \n",
       "11       PI3K/AKT/mTOR                            NaN   \n",
       "..                 ...                            ...   \n",
       "290       ER signaling                            NaN   \n",
       "291  targets KRAS G12C                            NaN   \n",
       "295      PI3K/AKT/mTOR                            NaN   \n",
       "298  targets KRAS G12C                            NaN   \n",
       "299              PRMT5                            NaN   \n",
       "\n",
       "    study-citations-used-for-patient comment-on-study-citation substrategy  \\\n",
       "2                                NaN                       NaN         NaN   \n",
       "5                                NaN                       NaN         NaN   \n",
       "7                                NaN                       NaN         NaN   \n",
       "9                                NaN                       NaN         NaN   \n",
       "11                               NaN                       NaN         NaN   \n",
       "..                               ...                       ...         ...   \n",
       "290                              NaN                       NaN         TKI   \n",
       "291                              NaN                       NaN         NaN   \n",
       "295                              NaN                       NaN         NaN   \n",
       "298                              NaN                       NaN         NaN   \n",
       "299                              NaN                       NaN         NaN   \n",
       "\n",
       "     almanac_top_recommendation_group  \n",
       "2                                 0.0  \n",
       "5                                 1.0  \n",
       "7                                 1.0  \n",
       "9                                 0.0  \n",
       "11                                0.0  \n",
       "..                                ...  \n",
       "290                               0.0  \n",
       "291                               1.0  \n",
       "295                               1.0  \n",
       "298                               1.0  \n",
       "299                               0.0  \n",
       "\n",
       "[121 rows x 11 columns]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "non_standard"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    107\n",
       "1     72\n",
       "Name: included-in-overlapping-strategy, dtype: int64"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standard = therapies[(therapies['almanac-evidence-strongest'].fillna('').isin(['FDA-Approved', 'Guideline']) | therapies['almanac-evidence-strongest'].isnull())]\n",
    "standard['included-in-overlapping-strategy'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "      <th>almanac_top_recommendation_group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2</td>\n",
       "      <td>crizotinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>MET</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1</td>\n",
       "      <td>I could not get access to this article; howeve...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Citation 2 describes clinical trials of CDK4 i...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>7</td>\n",
       "      <td>gemcitabine</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Chemotherapy</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>7</td>\n",
       "      <td>nab-paclitaxel</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Chemotherapy</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>9</td>\n",
       "      <td>bevacizumab</td>\n",
       "      <td>Inferential</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>VEGF/VEGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3</td>\n",
       "      <td>Citation 3 describes VEGF inhibition showing e...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>A042</td>\n",
       "      <td>irinotecan</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Antineoplastic</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>A042</td>\n",
       "      <td>denosumab</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>RANKL</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>A044</td>\n",
       "      <td>cyclophosphamide</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Chemotherapy</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>A044</td>\n",
       "      <td>dacarbazine</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Chemotherapy</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>A044</td>\n",
       "      <td>vincristine</td>\n",
       "      <td>Not based on molecular features</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>Chemotherapy</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>63 rows  11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id           therapy         study-evidence-strongest  \\\n",
       "0            2        crizotinib                   Clinical trial   \n",
       "1            5       palbociclib                   Clinical trial   \n",
       "3            7       gemcitabine  Not based on molecular features   \n",
       "4            7    nab-paclitaxel  Not based on molecular features   \n",
       "6            9       bevacizumab                      Inferential   \n",
       "..         ...               ...                              ...   \n",
       "281       A042        irinotecan  Not based on molecular features   \n",
       "283       A042         denosumab  Not based on molecular features   \n",
       "292       A044  cyclophosphamide  Not based on molecular features   \n",
       "293       A044       dacarbazine  Not based on molecular features   \n",
       "294       A044       vincristine  Not based on molecular features   \n",
       "\n",
       "    almanac-evidence-strongest  included-in-overlapping-strategy  \\\n",
       "0                    Guideline                                 1   \n",
       "1                    Guideline                                 1   \n",
       "3                          NaN                                 0   \n",
       "4                          NaN                                 0   \n",
       "6                          NaN                                 0   \n",
       "..                         ...                               ...   \n",
       "281                        NaN                                 0   \n",
       "283                        NaN                                 0   \n",
       "292                        NaN                                 0   \n",
       "293                        NaN                                 0   \n",
       "294                        NaN                                 0   \n",
       "\n",
       "           strategy  study-gave-as-matched-therapy  \\\n",
       "0               MET                            1.0   \n",
       "1            CDK4/6                            1.0   \n",
       "3      Chemotherapy                            0.0   \n",
       "4      Chemotherapy                            0.0   \n",
       "6        VEGF/VEGFR                            1.0   \n",
       "..              ...                            ...   \n",
       "281  Antineoplastic                            0.0   \n",
       "283           RANKL                            0.0   \n",
       "292    Chemotherapy                            0.0   \n",
       "293    Chemotherapy                            0.0   \n",
       "294    Chemotherapy                            0.0   \n",
       "\n",
       "    study-citations-used-for-patient  \\\n",
       "0                                  1   \n",
       "1                                  2   \n",
       "3                     Not applicable   \n",
       "4                     Not applicable   \n",
       "6                                  3   \n",
       "..                               ...   \n",
       "281                   Not applicable   \n",
       "283                   Not applicable   \n",
       "292                   Not applicable   \n",
       "293                   Not applicable   \n",
       "294                   Not applicable   \n",
       "\n",
       "                             comment-on-study-citation substrategy  \\\n",
       "0    I could not get access to this article; howeve...         NaN   \n",
       "1    Citation 2 describes clinical trials of CDK4 i...         NaN   \n",
       "3                                                  NaN         NaN   \n",
       "4                                                  NaN         NaN   \n",
       "6    Citation 3 describes VEGF inhibition showing e...         NaN   \n",
       "..                                                 ...         ...   \n",
       "281                                                NaN         NaN   \n",
       "283                                                NaN         NaN   \n",
       "292                                                NaN         NaN   \n",
       "293                                                NaN         NaN   \n",
       "294                                                NaN         NaN   \n",
       "\n",
       "     almanac_top_recommendation_group  \n",
       "0                                 1.0  \n",
       "1                                 1.0  \n",
       "3                                 NaN  \n",
       "4                                 NaN  \n",
       "6                                 NaN  \n",
       "..                                ...  \n",
       "281                               NaN  \n",
       "283                               NaN  \n",
       "292                               NaN  \n",
       "293                               NaN  \n",
       "294                               NaN  \n",
       "\n",
       "[63 rows x 11 columns]"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standard.drop_duplicates(['therapy', 'almanac-evidence-strongest'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>therapy</th>\n",
       "      <th>study-evidence-strongest</th>\n",
       "      <th>almanac-evidence-strongest</th>\n",
       "      <th>included-in-overlapping-strategy</th>\n",
       "      <th>strategy</th>\n",
       "      <th>study-gave-as-matched-therapy</th>\n",
       "      <th>study-citations-used-for-patient</th>\n",
       "      <th>comment-on-study-citation</th>\n",
       "      <th>substrategy</th>\n",
       "      <th>almanac_top_recommendation_group</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2</td>\n",
       "      <td>crizotinib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>MET</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1</td>\n",
       "      <td>I could not get access to this article; howeve...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Citation 2 describes clinical trials of CDK4 i...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>15</td>\n",
       "      <td>palbociclib</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>Guideline</td>\n",
       "      <td>1</td>\n",
       "      <td>CDK4/6</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Citation 2 describes clinical trials of CDK4 i...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>22</td>\n",
       "      <td>ado-trastuzumab emtansine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>ER signaling</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>23</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>Clinical trial</td>\n",
       "      <td>FDA-Approved</td>\n",
       "      <td>1</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>1.0</td>\n",
       "      <td>11,12,13,14,15</td>\n",
       "      <td>Citations looked at V600 mutants in different ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   patient_id                    therapy study-evidence-strongest  \\\n",
       "0           2                 crizotinib           Clinical trial   \n",
       "1           5                palbociclib           Clinical trial   \n",
       "8          15                palbociclib           Clinical trial   \n",
       "18         22  ado-trastuzumab emtansine                      NaN   \n",
       "20         23                  cetuximab           Clinical trial   \n",
       "\n",
       "   almanac-evidence-strongest  included-in-overlapping-strategy      strategy  \\\n",
       "0                   Guideline                                 1           MET   \n",
       "1                   Guideline                                 1        CDK4/6   \n",
       "8                   Guideline                                 1        CDK4/6   \n",
       "18               FDA-Approved                                 1  ER signaling   \n",
       "20               FDA-Approved                                 1          EGFR   \n",
       "\n",
       "    study-gave-as-matched-therapy study-citations-used-for-patient  \\\n",
       "0                             1.0                                1   \n",
       "1                             1.0                                2   \n",
       "8                             1.0                                2   \n",
       "18                            NaN                              NaN   \n",
       "20                            1.0                   11,12,13,14,15   \n",
       "\n",
       "                            comment-on-study-citation substrategy  \\\n",
       "0   I could not get access to this article; howeve...         NaN   \n",
       "1   Citation 2 describes clinical trials of CDK4 i...         NaN   \n",
       "8   Citation 2 describes clinical trials of CDK4 i...         NaN   \n",
       "18                                                NaN         NaN   \n",
       "20  Citations looked at V600 mutants in different ...         NaN   \n",
       "\n",
       "    almanac_top_recommendation_group  \n",
       "0                                1.0  \n",
       "1                                1.0  \n",
       "8                                1.0  \n",
       "18                               1.0  \n",
       "20                               1.0  "
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "standard = therapies[therapies['almanac-evidence-strongest'].fillna('').isin(['FDA-Approved', 'Guideline'])]\n",
    "standard.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "How many therapies does moalmanac highlight on average, that were not administered?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count    75.000000\n",
       "mean      2.066667\n",
       "std       1.338952\n",
       "min       1.000000\n",
       "25%       1.000000\n",
       "50%       2.000000\n",
       "75%       3.000000\n",
       "max       6.000000\n",
       "Name: patient_id, dtype: float64"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "therapies[~therapies['almanac-evidence-strongest'].isnull() & therapies['study-evidence-strongest'].isnull()]['patient_id'].value_counts().describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "moalmanac-paper",
   "language": "python",
   "name": "moalmanac-paper"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
